Kidney transplantation using complement inhibitor in a patient suffering from atypical hemolytic-uremic syndrome associated with factor H antibodies: successful prevention of recurrence of the underlying disease

Atypical hemolytic-uremic syndrome (aHUS) is an extremely rare complement-mediated disease that belongs to the group of thrombotic microangiopathies (TMA). It often reoccurs after kidney transplantation (KT). Previously, KT was considered contraindicated in both children and adults with aHUS due to...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: E. I. Prokopenko, S. A. Pasov, A. V. Vatazin, A. Ya. Tsalman, T. E. Pankratenko, G. A. Generalova
Materialtyp: Artigo
Språk:Russo
Publicerad: Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov 2020-07-01
Serie:Vestnik Transplantologii i Iskusstvennyh Organov
Ämnen:
atypical hemolytic-uremic syndrome
eculizumab
kidney transplantation
complement-activating conditions
Länkar:https://journal.transpl.ru/vtio/article/view/1194
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk